The panel discussion saw sharing of insights from speakers representing UKM, Duopharma Biotech, the Department of Islamic Development Malaysia (JAKIM), HDC, the Ministry of Defence and the Malaysian Pharmacist Society. As our longstanding R&D partner in Halal pharmaceutical science and commercial applications, we have made significant progress together and look forward to reaching many more milestones. Through this symposium, Duopharma Biotech is maintaining our momentum in spearheading strategic collaborations to capture fast-growing potential in the Halal pharmaceutical industry and elevate the position of Halal pharmaceuticals within the global pharmaceutical landscape." Dr Mohd Ekhwan Hj Toriman, Vice-Chancellor, Universiti Kebangsaan Malaysia, emphasised the importance of academic research in advancing the Halal pharmaceutical sector. Malaysia's Halal industry is projected to expand to USD113.2 billion by 2030, with a GDP contribution of 8.1% by 2025 through the Halal Industry Master Plan 2030, spurred by the Government's aim to elevate Malaysia's position as a key player in the global Halal market.

Source: thestar November 18, 2024 10:46 UTC